Ardelyx is trading up 6.27% in pre-market at $3.22, following its November 3 earnings report, the clearest catalyst for the gain.

  • The quarter showed near-break-even results, including a $0.7 million net loss.
  • IBSRELA revenue was $96.3 million, up 23% year over year; management reaffirmed 2026 product revenue guidance and its 2027 profitability target.